Forward Citations = 3

Loading Chart...

3 inventors (with patents filed for the assignee):

Marc Barry Brown (3 out of 35 patents)

Cameron Robert Stevenson (3 out of 4 patents)

Charles Rodney Greenaway Evans (3 out of 18 patents)

3 patents: Sort by Forward Citations

1. 11413283 - Topical formulations for delivery of hedgehog inhibitor compounds and use thereof (2022-08-16),

2. 10695344 - Topical formulations for delivery of hedgehog inhibitor compounds and use thereof (2020-06-30),

3. 10369147 - Topical formulations for delivery of hedgehog inhibitor compounds and use thereof (2019-08-06),

Company Overview

Pellepharm, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with rare dermatologic conditions. With a mission to improve the lives of those affected by these diseases, Pellepharm is dedicated to advancing research and delivering cutting-edge treatments. Through collaboration with patients, physicians, and researchers, Pellepharm aims to bring hope and relief to those in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#1,079 in San Francisco, CA

#16,867 in California

#73,904 in US

San Francisco, CA, United States of America

Pellepharm, Inc.

Forward Citations = 3

3 inventors:

Marc Barry Brown (3 out of 35 patents)

Cameron Robert Stevenson (3 out of 4 patents)

Charles Rodney Greenaway Evans (3 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pellepharm, Inc.. Retrieved from https://idiyas.com/company/pellepharm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]